Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Transplant Proc ; 46(5): 1517-22, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24935323

ABSTRACT

BACKGROUND: The aim of this study was to investigate the relationship between donor-to-recipient weight ratio and post-transplantation survival. METHODS: From February 1988 to November 2006, 255 adult bilateral lung transplantation patients from 2 different centers were retrospectively analyzed. The cohort was divided into 4 groups depending on the quartile ranges of the donor-to-recipient weight ratio. A time-to-event analysis was performed for risk of death after transplantation conditional on 5-year survival using Kaplan-Meier and Cox proportional hazards models. RESULTS: The mean weight ratio for the study cohort was 1.23 ± 0.39. For all lung transplant recipients during the study period, survival rate at 5 years was 58%. Median survival was 6.3 years in the cohort subgroup with weight ratio <1.23, whereas the median survival was 7.7 years for the cohort subgroup with weight ratio >1.23. Weight ratio >1.23 recipients had a significant survival advantage out to 5 years compared with weight ratio <1.23 recipients (66.1% vs 51.1%, P = .0126). With the aim to assess underweight and overweight donors vs recipients, we have divided all patients into 4 groups, from quartile 1 to 4, based on donor-to-recipient weight ratio. Weight ratio strata affected overall survival, with quartile 1 (lower weight ratio recipients) experiencing the lowest 5-year survival (39.1%), followed by quartile 2 (57.8%), quartile 4 (68.2%), and quartile 3 (70.3%) recipients. The effect of weight ratio strata on survival was statistically significant for the quartile 1 recipients (lower quartile) as compared with the 3 other quartiles. CONCLUSIONS: Our findings show a statistically significant effect of donor-to-recipient weight ratios on bilateral lung transplantation survival. A higher donor-to-recipient weight ratio was associated with improved survival after bilateral lung transplantation and likely reflects a mismatch between a relatively overweight donor vs recipient. In contrast, a lower donor-to-recipient ratio was associated with increased mortality after bilateral lung transplantation.


Subject(s)
Body Weight , Lung Transplantation , Survival Rate , Tissue Donors , Transplant Recipients , Adult , Cohort Studies , Female , Humans , Male , Middle Aged
2.
Oncogene ; 32(20): 2499-509, 2013 May 16.
Article in English | MEDLINE | ID: mdl-22945652

ABSTRACT

Clinical studies have defined the core 'genetic blueprint' of a cancer cell, but this information does not necessarily predict the cancer phenotype. Signalling hubs that mediate such phenotype have been identified largely using OMICS platforms that measure dynamic molecular changes within the cancer cell landscape. The pro-oncogenic protein anterior gradient 2 (AGR2) is a case in point; AGR2 has been shown using a range of expression platforms to be involved in asthma, inflammatory bowel disease, cell transformation, cancer drug resistance and metastatic growth. AGR2 protein is also highly overexpressed in a diverse range of human cancers and can be secreted and detected in extracellular fluids, thus representing a compelling pro-oncogenic signalling intermediate in human cancer. AGR2 belongs to the protein disulphide isomerase family with all the key features of an endoplasmic reticulum-resident protein-this gives clues into how it might function as an oncoprotein through the regulation of protein folding, maturation and secretion that can drive metastatic cell growth. In this review, we will describe the known aspects of AGR2 molecular biology, including gene structure and regulation, emerging protein interaction networks and how its subcellular localization mediates its biological functions. We will finally review the cases of AGR2 expression in human cancers, the pathophysiological consequences of AGR2 overexpression, its potential role as a tumour biomarker that predicts the response to therapy and how the AGR2 pathway might form the basis for drug discovery programmes aimed at targeting protein folding/maturation pathways that mediate secretion and metastasis.


Subject(s)
Endoplasmic Reticulum/metabolism , Gene Expression Regulation, Neoplastic , Neoplasms/genetics , Proteins/genetics , Proteins/metabolism , Amino Acid Motifs , Androgens/metabolism , Animals , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Drug Resistance, Neoplasm , Estrogens/metabolism , Extracellular Fluid/metabolism , Female , Gene Expression Regulation, Developmental , Humans , Mucoproteins , Multigene Family , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/physiopathology , Oncogene Proteins , Promoter Regions, Genetic , Protein Interaction Maps , Tamoxifen/pharmacology
3.
Transplant Proc ; 43(10): 3899-902, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22172868

ABSTRACT

BACKGROUND: In the current practice of lung transplantation, donor and recipient genders are neither directly considered nor matched. However, some data have suggested a possible effect of gender combinations on survival following lung transplantation. METHODS: A total of 249 adult lung transplant recipients at a single center between February 1988 and December 2008, were analyzed retrospectively for donor-recipient gender matching. We compared the mortality by calculating one-term survival rates after transplantation using the Kaplan-Meier method with comparisons using the log-rank (Mantel-Cox) test. Statistical significance of the mean effects of size matching was assessed by paired Student t tests and Wilcoxon signed rank tests. RESULTS: Kaplan-Meier survival analysis shown that male compared to female recipients did not have an effect on outcomes after lung transplantation at 5 years (P=.5379), 10 years (P=.107), 15 years (P=.0841), 20 years (P=.0711). No effect of gender on lung transplantation outcomes was observed with donor-recipient gender mismatches at 5 years (P=.1804), 10 years (P=.1457), 15 years (P=.0731), or 20 years (P=.0629). Similarly, no differences were observed for each gender combination. The degree of size matching was defined as the ratio of donor-to-recipient predicted total lung capacity. The ratios were similar for the donor-recipient gender match and significantly different for the donor-recipient gender mismatch. CONCLUSIONS: These analyses suggested that gender was not a significant independent risk factor affecting survival after lung transplantation. Size mismatch caused by gender mismatch did not increase mortality.


Subject(s)
Lung Transplantation/mortality , Tissue Donors/statistics & numerical data , Adult , Female , France , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Retrospective Studies , Risk Assessment , Risk Factors , Sex Factors , Survival Rate , Time Factors , Treatment Outcome , Young Adult
4.
Oncogene ; 29(46): 6102-14, 2010 Nov 18.
Article in English | MEDLINE | ID: mdl-20697343

ABSTRACT

Children with Down's syndrome (DS) have 20-50-fold higher incidence of all leukaemias (lymphoid and myeloid), for reasons not understood. As incidence of many solid tumours is much lower in DS, we speculated that disturbed early haematopoietic differentiation could be the cause of increased leukaemia risk. If a common mechanism is behind the risk of both major leukaemia types, it would have to arise before the bifurcation to myeloid and lymphoid lineages. Using the transchromosomic system (mouse embryonic stem cells (ESCs)) bearing an extra human chromosome 21 (HSA21)) we analyzed the early stages of haematopoietic commitment (mesodermal colony formation) in vitro. We observed that trisomy 21 (T21) causes increased production of haemogenic endothelial cells, haematopoietic stem cell precursors and increased colony forming potential, with significantly increased immature progenitors. Transchromosomic colonies showed increased expression of Gata-2, c-Kit and Tie-2. A panel of partial T21 ESCs allowed us to assign these effects to HSA21 sub-regions, mapped by 3.5 kbp-resolution tiling arrays. The Gata-2 increase on one side, and c-Kit and Tie-2 increases on the other, could be attributed to two different, non-overlapping HSA21 regions. Using human-specific small interfering RNA silencing, we could demonstrate that an extra copy of RUNX1, but not ETS-2 or ERG, causes an increase in Tie-2/c-Kit levels. Finally, we detected significantly increased levels of RUNX1, C-KIT and PU.1 in human foetal livers with T21. We conclude that overdose of more than one HSA21 gene contributes to the disturbance of early haematopoiesis in DS, and that one of the contributors is RUNX1. As the observed T21-driven hyperproduction of multipotential immature precursors precedes the bifurcation to lymphoid and myeloid lineages, we speculate that this could create conditions of increased chance for acquisition of pre-leukaemogenic rearrangements/mutations in both lymphoid and myeloid lineages during foetal haematopoiesis, contributing to the increased risk of both leukaemia types in DS.


Subject(s)
Chromosomes, Human, Pair 21 , Down Syndrome/complications , Hematopoietic Stem Cells/cytology , Leukemia/etiology , Animals , Cell Differentiation , Cells, Cultured , Core Binding Factor Alpha 2 Subunit/physiology , Down Syndrome/genetics , Embryonic Stem Cells/cytology , GATA2 Transcription Factor/genetics , Hematopoiesis , Humans , Mice , Proto-Oncogene Proteins c-kit/genetics
5.
Cell Death Differ ; 14(3): 586-96, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16858427

ABSTRACT

The endoplasmic reticulum (ER) has evolved specific mechanisms to ensure protein folding as well as the maintenance of its own homeostasis. When these functions are not achieved, specific ER stress signals are triggered to activate either adaptive or apoptotic responses. Here, we demonstrate that MCF-7 cells are resistant to tunicamycin-induced apoptosis. We show that the expression level of the ER chaperone calnexin can directly influence tunicamycin sensitivity in this cell line. Interestingly, the expression of a calnexin lacking the chaperone domain (DeltaE) partially restores their sensitivity to tunicamycin-induced apoptosis. Indeed, we show that DeltaE acts as a scaffold molecule to allow the cleavage of Bap31 and thus generate the proapoptotic p20 fragment. Utilizing the ability of MCF-7 cells to resist tunicamycin-induced apoptosis, we have characterized a molecular mechanism by which calnexin regulates ER-stress-mediated apoptosis in a manner independent of its chaperone functions but dependent of its binding to Bap31.


Subject(s)
Breast Neoplasms/metabolism , Calnexin/metabolism , Carcinoma/metabolism , Gene Expression Regulation, Neoplastic , Tunicamycin/pharmacology , Amino Acid Sequence , Apoptosis , Calnexin/genetics , Calnexin/physiology , Caspase 3/metabolism , Cell Line, Tumor , Clone Cells , Drug Resistance, Neoplasm , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Enzyme Activation , Humans , Molecular Sequence Data
6.
J Endocrinol ; 170(1): 217-26, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11431154

ABSTRACT

Thyroglobulin (Tg) binds to cell surfaces through various binding sites of high, moderate and low affinity. We have previously shown that binding with low to moderate affinity is pH dependent, selective, but not tissue specific. To identify the regions of Tg involved in this cell surface binding, we studied the binding of (125)I-labeled cyanogen bromide peptides from human Tg to cell surfaces of thyroid cells (inside-out follicles) and of CHO cells. Electrophoretic analysis of cell homogenates after binding of native or of reduced and alkylated (125)I-labeled peptides showed that three peptides, P1, P2 and P3, were always associated with the cells. Sequence analysis allowed the identification of P1 (Ser-2445 to Met-2596 or Met-2610) and P2 (Phe-2156 to Met-2306). P3 proved to be a mixture of several peptides among which two were identified: P3-1 (Cys-1306 to Met-1640) and P3-2 (Cys-2035 to Met-2413) which includes P2. P1, P2 and P3-2 are entirely (P1) or partly (P2 and P3-2) located in the C-terminal domain of Tg homologous with acetylcholinesterase. The smallest peptides, P1 and P2, were purified by preparative electrophoresis. They both displayed strong binding properties towards cell surfaces. Inhibition experiments of (125)I-labeled Tg binding by P1 or P2 indicated that they were involved in Tg binding to cell surfaces. All the other peptides tested for their binding abilities were either not or only poorly involved in Tg binding to cell surfaces, which suggested that P1 and P2 are major Tg sites of binding to cell surfaces. These two peptides are not involved in the binding of Tg to the known Tg 'receptors' described in the literature, to which recycling, transcytosis and regulation functions have been ascribed. Thus they are potential tools to identify cell surface components involved in the process of Tg endocytosis leading to lysosomal degradation.


Subject(s)
Receptors, Cell Surface/metabolism , Thyroglobulin/metabolism , Thyroid Gland/metabolism , Amino Acid Sequence , Animals , Cell Membrane/metabolism , Cells, Cultured , Electrophoresis, Polyacrylamide Gel , Endocytosis , Humans , Lysosomes/metabolism , Molecular Sequence Data , Peptide Fragments/genetics , Protein Binding , Swine , Thyroglobulin/genetics
7.
J Biol Chem ; 276(24): 21337-42, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11294872

ABSTRACT

The process of thyroid hormone synthesis, which occurs in the lumen of the thyroid follicles, results from an oxidative reaction leading, as side effects, to the multimerization of thyroglobulin (TG), the prothyroid hormone. Although hormone synthesis is a continuous process, the amount of Tg multimers is relatively constant. Here, we investigated the role of two molecular chaperones, protein disulfide isomerase (PDI) and immunoglobulin heavy chain-binding protein (BiP), present in the follicular lumen, on the multimerization process due to oxidation using both native Tg and its N-terminal domain (NTD). In vitro, PDI decreased multimerization of Tg and even suppressed the formation of NTD multimers. Under the same conditions, BiP was able to bind to Tg and NTD multimers but did not affect the process of multimerization. Associating BiP with PDI did not enhance the ability of PDI to limit the formation of multimers produced by oxidation. However, when BiP and PDI were reacted together with the multimeric forms and for a longer time (48 h), BiP greatly increased the efficiency of PDI. Accordingly, these two molecular chaperones probably act sequentially on the reduction of the intermolecular disulfide bridges. In the thyroid, a similar process may also be effective and participate in limiting the amount of Tg multimers present in the colloid. These results suggest that extracellular molecular chaperones play a similar role to that occurring in the endoplasmic reticulum and, furthermore, take part in the control of multimerization and aggregation of proteins formed by oxidation.


Subject(s)
Carrier Proteins/metabolism , Heat-Shock Proteins , Molecular Chaperones/metabolism , Protein Disulfide-Isomerases/metabolism , Protein Folding , Thyroglobulin/chemistry , Thyroglobulin/metabolism , Colloids , Endoplasmic Reticulum Chaperone BiP , Extracellular Space/physiology , Goiter/metabolism , Humans , Immunoglobulin Heavy Chains/chemistry , Immunoglobulin Heavy Chains/metabolism , Macromolecular Substances , Oxidation-Reduction , Protein Denaturation , Thyroid Gland/metabolism
8.
Endocrinology ; 141(7): 2518-25, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10875253

ABSTRACT

Here, we studied the fragmentation of the prothyroid hormone, thyroglobulin (Tg), which occurs during thyroid hormone synthesis, a process which involves iodide, thyroperoxidase, and the H2O2-generating system, consisting of glucose and glucose oxidase. Various peptides were found to be immunoreactive to autoantibodies to Tg from patients and monoclonal antibodies directed against the immunodominant region of Tg. The smallest peptide (40 kDa) bore thyroid hormones and was identified at the C-terminal end of the Tg molecule, which shows homologies with acetylcholinesterase. Similar peptides were obtained by performing metal-mediated oxidation of Tg via a Fenton reaction. It was concluded that the oxidative stress induced during hormone synthesis generates free radicals, which, in turn, cleave Tg into immunoreactive peptides.


Subject(s)
Peptide Fragments/biosynthesis , Thyroglobulin/biosynthesis , Thyroid Hormones/biosynthesis , Amino Acid Sequence/genetics , Epitope Mapping , Humans , Immunologic Techniques , Molecular Sequence Data , Molecular Weight , Peptide Fragments/chemistry , Peptide Fragments/immunology , Peptide Fragments/metabolism , Reactive Oxygen Species/metabolism , Thyroglobulin/immunology , Thyroglobulin/metabolism , Tissue Distribution
9.
Biochem Biophys Res Commun ; 255(2): 438-43, 1999 Feb 16.
Article in English | MEDLINE | ID: mdl-10049727

ABSTRACT

Reactive oxygen species (ROS) are involved in many pathological processes through modifications of structure and activity of proteins. ROS also participate in physiological pathways such as thyroid hormone biosynthesis, which proceeds through oxidation of the prothyroid hormone (thyroglobulin, Tg) and iodide. Regarding the colloidal insoluble multimerized Tg (m-Tg), which bears dityrosine bridges and is present in the follicular lumen, a mild oxidative system generated different soluble forms of Tg, more or less compacted by hydrophobic associations, and linked with Grp78 and Grp94. In vitro, the combined action of ROS and PDI, in the presence of free glutathione (reduced/oxidized), increased the solubility of this misassembled Tg and partially restored the ability of Tg to synthesize hormones. Our results show that protein chaperones escape from the ER and are involved with ROS in thyroid hormone synthesis. Therefore, we propose a model of roles of m-Tg in the follicular lumen.


Subject(s)
Extracellular Space/physiology , Heat-Shock Proteins , Molecular Chaperones/physiology , Reactive Oxygen Species/physiology , Thyroglobulin/metabolism , Thyroid Gland/metabolism , Carrier Proteins/isolation & purification , Chemical Fractionation , Endoplasmic Reticulum Chaperone BiP , Goiter/metabolism , Goiter/pathology , HSP70 Heat-Shock Proteins/isolation & purification , Humans , Hydrolysis , Membrane Proteins/isolation & purification , Models, Biological , Molecular Chaperones/isolation & purification , Oxidation-Reduction , Polymers/chemistry , Protein Disulfide-Isomerases/metabolism , Protein Folding , Solubility , Thyroglobulin/chemistry , Thyroid Gland/pathology , Tyrosine/analogs & derivatives , Tyrosine/metabolism
10.
Biochem Biophys Res Commun ; 242(2): 292-6, 1998 Jan 14.
Article in English | MEDLINE | ID: mdl-9446787

ABSTRACT

Thyroglobulin (Tg), the prothyroid hormone, is stored in the lumen of the thyroid follicles as soluble dimers and tetramers and insoluble multimers, Soluble Tg is well characterized with regards to structure and role, but insoluble Tg (i-Tg) is not. Here we show that i-Tg, multimerized through formation of disulfide and dityrosine bonds, has a higher iodine content than soluble Tg and no thyroid hormones. Furthermore, the size and the resistance of i-Tg to proteolytic enzymes implied a new mechanism by which thyrocytes may degrade this form of Tg. Using peroxidase and H2O2 generating system, we found that about 80% of i-Tg was degraded and 24% of its iodine content was released. Our data point to a role for i-Tg in iodine storage and the involvement of TPO in i-Tg degradation and iodide release.


Subject(s)
Iodine/metabolism , Protein Conformation , Thyroglobulin/metabolism , Amino Acids/analysis , Animals , Diiodotyrosine/analysis , Disulfides/chemistry , Electrophoresis, Polyacrylamide Gel , Hydrogen Peroxide/metabolism , Iodides/analysis , Iodine/analysis , Microscopy, Electron, Scanning , Monoiodotyrosine/analysis , Peroxidase/metabolism , Pronase/metabolism , Swine , Thyroglobulin/analysis , Thyroglobulin/chemistry , Thyroglobulin/isolation & purification , Thyroid Gland/chemistry , Thyroid Gland/enzymology , Thyroid Gland/metabolism , Thyroxine/analysis , Triiodothyronine/analysis , Trypsin/metabolism , Tyrosine/analogs & derivatives , Tyrosine/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...